Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mirati Therapeutics
(NQ:
MRTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Mirati Therapeutics
< Previous
1
2
3
4
5
6
7
Next >
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
December 13, 2022
Gainers Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.
Via
Benzinga
Another Competitor For Amgen As FDA Approves Mirati Therapeutics' KRAS Inhibitor For Lung Cancer Setting
December 13, 2022
Via
Benzinga
Pinterest, Oracle And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
December 13, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. ACM Research, Inc. (NASDAQ: ACMR) shares jumped 25.9% to $10.98 in...
Via
Benzinga
Why Mirati Therapeutics Shares Are Nosediving
December 09, 2022
Mirati Therapeutics Inc (NASDAQ: MRTX) shares are trading lower by 4.90% to $41.70 after Citigroup downgraded the stock from Buy to Neutral.
Via
Benzinga
BMO Capital Downgrades Mirati Therapeutics: Here's What You Need To Know
December 08, 2022
Via
Benzinga
What 10 Analyst Ratings Have To Say About Mirati Therapeutics
December 08, 2022
Via
Benzinga
Where Mirati Therapeutics Stands With Analysts
December 08, 2022
Via
Benzinga
Nasdaq, S&P 500 Futures Soar Amid Optimistic Expectations Concerning Nov. Inflation: Oracle, Tesla, Pinterest Among Early Movers
December 13, 2022
The index futures point to a modestly higher opening for the market on Tuesday, although the November consumer price inflation due ahead of the open could sway sentiment either way depending on how the...
Via
Benzinga
Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing Continues
December 12, 2022
FDA action on its KRAS-blocking drug could help recently downtrodden Mirati.
Via
Investor's Business Daily
Why Mirati Therapeutics Stock Lost Half Its Value In Just Three Days
December 08, 2022
The company is still planning a Phase 3 study in non-small cell lung cancer.
Via
Investor's Business Daily
Why Mirati Therapeutics Shares Are Getting Hammered Again Today
December 08, 2022
Mirati Therapeutics Inc (NASDAQ: MRTX) shares are trading lower by 12.18% to $43.55 during Thursday's session after multiple analysts downgraded their ratings on the stock and lowered their price...
Via
Benzinga
Chefs' Warehouse, Chart Industries And Some Other Big Stocks Moving Lower On Thursday
December 08, 2022
U.S. stocks traded higher, with the Dow Jones jumping over 200 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session
December 08, 2022
Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split.
Via
Benzinga
Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday
December 08, 2022
Via
Benzinga
Why Shares of Mirati Therapeutics Fell Wednesday
December 07, 2022
The company presented phase 2 data from its non-small cell lung cancer therapy.
Via
The Motley Fool
Why Mirati Therapeutics Stock Is Trading Sharply Lower Today
December 07, 2022
Mirati Therapeutics Inc (NASDAQ: MRTX) shares are trading lower by 29.32% to $50.55 on continued weakness after the company announced late-breaking results
Via
Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
December 07, 2022
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 07, 2022
Via
Benzinga
United Natural Foods, Ollie's Bargain, Smith & Wesson Brands And Some Other Big Stocks Moving Lower On Wednesday
December 07, 2022
U.S. stocks traded mostly lower, with the Nasdaq Composite dropping over 60 points on Wednesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Shares of Mirati Therapeutics Fell Tuesday
December 06, 2022
Investors and analysts were unimpressed by trial results on the company's combination therapy to treat non-small cell lung cancer.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 06, 2022
Via
Benzinga
Meta Platforms, Herbalife And Some Other Big Stocks Moving Lower On Tuesday
December 06, 2022
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
December 06, 2022
Gainers Summit Therapeutics Inc. (NASDAQ: SMMT) shares surged 82.2% to $1.4299 after the company announced a definitive agreement of its partnership with Akeso to in-license its breakthrough bispecific...
Via
Benzinga
Mirati Therapeutics Crashes As The Cancer Rivalry With Amgen Heats Up
December 06, 2022
The combination with Keytruda appears safe, but effectiveness questions persist.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 06, 2022
Via
Benzinga
Why MEI Pharma Shares Are Trading Lower By Around 35%; Here Are 20 Stocks Moving Premarket
December 06, 2022
Gainers Starry Group Holdings, Inc. (NYSE: STRY) shares rose 43.5% to $0.2011 in pre-market trading after dipping more than 20% on Monday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 06, 2022
Good morning, trader! We're starting off the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!
Via
InvestorPlace
Mirati Experimental Lung Cancer Drug Shows Favorable Tolerability, Promising Efficacy
December 06, 2022
Via
Benzinga
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year trail 2021’s tally by about 35%.
Via
Benzinga
Mirati Therapeutics Surges As Big Pharma Reportedly Preps For A Buyout Battle
November 23, 2022
There are reportedly numerous companies in the mix and they're all awaiting data next month.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.